Recently, Beijing Phil Rivers Technology Co., Ltd. (Phil Rivers Tech) announced that it had completed the Series-A funding. This round of financing is led by Bohong Capital and Taiya Capital, followed by Higginger Pharmaceutical. This round of financing will be used to upgrade the "computational medicine" platform and promote the self-developed pipeline.